BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 8578519)

  • 1. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the v-mpl oncogene to thrombopoietin.
    Methia N; Debili N; Titeux M; Vainchenker W; Wendling F
    C R Acad Sci III; 1995 Apr; 318(4):479-82. PubMed ID: 7648360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.
    Vigon I; Florindo C; Fichelson S; Guenet JL; Mattei MG; Souyri M; Cosman D; Gisselbrecht S
    Oncogene; 1993 Oct; 8(10):2607-15. PubMed ID: 8397366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
    Souyri M
    Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J; Sabath DF; Kuter DJ
    Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mpl ligand (thrombopoietin) and platelet regulation].
    Wendling F; Cohen-Solal K; Debili N; Villeval JL; Titeux M; Vainchenker W
    Ann Pharm Fr; 1996; 54(4):177-82. PubMed ID: 8881104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cMpl ligand is a humoral regulator of megakaryocytopoiesis.
    Wendling F; Maraskovsky E; Debili N; Florindo C; Teepe M; Titeux M; Methia N; Breton-Gorius J; Cosman D; Vainchenker W
    Nature; 1994 Jun; 369(6481):571-4. PubMed ID: 8202160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of thrombopoietin and its receptor c-Mpl in regulation of thrombocytopoiesis in thrombocytopenia].
    Strauss G; Ballmaier M; Schulze H; Bogenberger J; Riehm H; Welte K
    Klin Padiatr; 1996; 208(4):168-71. PubMed ID: 8926683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
    Griesshammer M; Bangerter M; Schrezenmeier H
    Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
    Chen Q; Solar G; Eaton DL; de Sauvage FJ
    Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.